Survival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database

<b>Background:</b> Chronic Myelomonocytic Leukemia (CMML) is a rare and aggressive form of leukemia with characteristics of both myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDSs). This study aims to explore the clinical features, survival outcomes, and prognostic factors in CM...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Ayrton Bangolo, Behzad Amoozgar, Abhishek Thapa, Wardah Bajwa, Vignesh K. Nagesh, Yaryna Nyzhnyk, Rakshanda Banu, Tirth Bhavsar, Lili Zhang, Olga Velichko, Challa Mani Shankar Reddy, Edwina Essuman, Amal M. Ibrahim, Ramkumar Krishnasamy, Achint Jethi, Arun Ram, Abdullah A. Haq, Abdulla Ahmad Al hashm, Parna Pathak, Shafia Naeem, Rachana R. Gavva, Prajakta H. Ratnaparkhi, Paula Samaha, Cynthia Elizabeth Armendariz Espinoza, Prasansa Dhakal, Frantz Ricot Martine, Mogahid Elkhidir, Jay Mehta, Simcha Weissman
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2024-10-01
سلاسل:	Medical Sciences
الموضوعات:	Chronic Myelomonocytic Leukemia mortality prognosis cytogenetics incidence prevalence
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-3271/12/4/60
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!